Overview
CytoVale is a US provider of precise blood analysis at the single-cell level.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $84M (Series C), Nov 16, 2023.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Nov 16, 2023 | $84M · Series C | Global Health Investment Corporation, Norwest Venture Partners, Sands Capital | No source link |
Evidence No source brief is attached to this record. Sources · 0
Global Health Investment Corporation, Norwest Venture Partners, Sands Capital | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Nov 16, 2023 | — · Series C | Global Health Investment Corporation, Norwest Venture Partners, Sands Capital | No source link |
Evidence No source brief is attached to this record. Sources · 0
Global Health Investment Corporation, Norwest Venture Partners, Sands Capital | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
一家美国单细胞级的血液精准分析服务商 CytoVale是一家美国单细胞级的血液精准分析服务商